{"disease":{"id":"central-nervous-system-metastases","name":"central nervous system metastases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07462507","title":"Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":104,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT02753790","title":"Whole Brain Radiation Using IMRT for Patients With Brain Metastases","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"New Mexico Cancer Research Alliance","has_results":false},{"nct_id":"NCT06322342","title":"Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Reveal Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT02650752","title":"Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03789149","title":"Focal Intraoperative Radiotherapy of Brain Metastases","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"AC Camargo Cancer Center","has_results":false},{"nct_id":"NCT01783756","title":"Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT01706432","title":"Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT03711422","title":"Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"National Cancer Centre, Singapore","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}